These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22677730)

  • 1. Oncolytic viruses: a new paradigm for treatment of head and neck cancer.
    Lott JB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):155-60. PubMed ID: 22677730
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.
    Dias JD; Guse K; Nokisalmi P; Eriksson M; Chen DT; Diaconu I; Tenhunen M; Liikanen I; Grénman R; Savontaus M; Pesonen S; Cerullo V; Hemminki A
    Eur J Cancer; 2010 Feb; 46(3):625-35. PubMed ID: 20006487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H
    Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
    Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
    Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
    Zhu ZB; Mathis JM; Makhija SK; Lu B; Wang M; Ji S; Rivera AA; Rosenthal EL; Siegal GP; Curiel DT
    Int J Oncol; 2007 Nov; 31(5):1213-22. PubMed ID: 17912450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase-specific virotheranostics for human head and neck cancer.
    Kurihara Y; Watanabe Y; Onimatsu H; Kojima T; Shirota T; Hatori M; Liu D; Kyo S; Mizuguchi H; Urata Y; Shintani S; Fujiwara T
    Clin Cancer Res; 2009 Apr; 15(7):2335-43. PubMed ID: 19318473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Ge Y; VanRoey M; Robinson M; Jooss K
    Cancer Gene Ther; 2009 May; 16(5):383-92. PubMed ID: 19011598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
    Toivonen R; Suominen E; Grenman R; Savontaus M
    Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.
    Haddad R; Norris CM; Posner MR
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):58-60; discussion 61-2. PubMed ID: 16227961
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma.
    Mace AT; Harrow SJ; Ganly I; Brown SM
    Acta Otolaryngol; 2007 Aug; 127(8):880-7. PubMed ID: 17763002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site.
    Graff P; Schipman B; Desandes E; Mecellem H; Toussaint B; Cortese S; Marchal F; Kaminsky MC; Geoffrois L; Peiffert D
    Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):174-81. PubMed ID: 21130631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier cell-mediated cell lysis of squamous cell carcinoma cells by squamous cell carcinoma antigen 1 promoter-driven oncolytic adenovirus.
    Hamada K; Zhang T; Desaki J; Nakashiro K; Itoh H; Tani K; Koyama Y; Hamakawa H
    J Gene Med; 2010 Jun; 12(6):545-54. PubMed ID: 20527047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
    Carlson GW
    Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of a stochastic model to response assessments in a study of squamous cell carcinoma of the head and neck.
    Hassani H
    Pharm Stat; 2012; 11(6):462-7. PubMed ID: 22962036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer of the head and neck: nonsurgical treatment.
    Ermertcan AT; Hellings PW; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):445-54. PubMed ID: 23084297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck squamous cell carcinomas.
    Fayette J
    Anticancer Drugs; 2011 Aug; 22(7):585. PubMed ID: 21705866
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted genetic and viral therapy for advanced head and neck cancers.
    Huang PI; Chang JF; Kirn DH; Liu TC
    Drug Discov Today; 2009 Jun; 14(11-12):570-8. PubMed ID: 19508919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer: state of the art.
    Atiyah RA
    J Med Liban; 1994; 42(4):216-20. PubMed ID: 8558581
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction chemotherapy in head and neck cancer: a new paradigm.
    Pointreau Y; Atean I; Fayette J; Calais G; Lefebvre JL
    Anticancer Drugs; 2011 Aug; 22(7):613-20. PubMed ID: 21160420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.